Loading clinical trials...
Loading clinical trials...
Age-related vision impairment and dementia both become more prevalent with increasing age. Research into the mechanisms of these conditions has proposed that some of their causes (e.g., macular degene...
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
Université de Montréal
Collaborators
NCT07440225 · Macular Degeneration, Age-Related Macular Degeneration, and more
NCT07545473 · Dementia, Neurodegenerative Diseases, and more
NCT05407636 · AMD, nAMD, and more
NCT07531732 · Frontotemporal Dementia, Behavioral Variant, Alzheimer Disease
NCT07308639 · Neovascular Age-related Macular Degeneration (nAMD); Diabetic Macular Edema (DME); Retinal Vein Occlusion (RVO)
Institut Nazareth et Louis-Braille du CISSS de la Montérégie-Centre
Longueuil, Quebec
Centre de réadaptation Lethbridge-Layton-Mackay du CIUSSS du Centre-Ouest-de-l'Île-de-Montréal
Montreal, Quebec
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions